SG11201509715UA - Preventing or mitigating chemotherapy induced alopecia using vitamin d - Google Patents

Preventing or mitigating chemotherapy induced alopecia using vitamin d

Info

Publication number
SG11201509715UA
SG11201509715UA SG11201509715UA SG11201509715UA SG11201509715UA SG 11201509715U A SG11201509715U A SG 11201509715UA SG 11201509715U A SG11201509715U A SG 11201509715UA SG 11201509715U A SG11201509715U A SG 11201509715UA SG 11201509715U A SG11201509715U A SG 11201509715UA
Authority
SG
Singapore
Prior art keywords
vitamin
preventing
chemotherapy induced
induced alopecia
mitigating chemotherapy
Prior art date
Application number
SG11201509715UA
Inventor
Niven Rajin Narain
John Patrick Mccook
Joaquin J Jimenez
Original Assignee
Berg Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berg Llc filed Critical Berg Llc
Publication of SG11201509715UA publication Critical patent/SG11201509715UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dispersion Chemistry (AREA)
SG11201509715UA 2013-05-29 2014-05-29 Preventing or mitigating chemotherapy induced alopecia using vitamin d SG11201509715UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361828448P 2013-05-29 2013-05-29
PCT/US2014/040084 WO2014194133A1 (en) 2013-05-29 2014-05-29 Preventing or mitigating chemotherapy induced alopecia using vitamin d

Publications (1)

Publication Number Publication Date
SG11201509715UA true SG11201509715UA (en) 2015-12-30

Family

ID=51989403

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201709894RA SG10201709894RA (en) 2013-05-29 2014-05-29 Preventing or mitigating chemotherapy induced alopecia using vitamin d
SG11201509715UA SG11201509715UA (en) 2013-05-29 2014-05-29 Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201709894RA SG10201709894RA (en) 2013-05-29 2014-05-29 Preventing or mitigating chemotherapy induced alopecia using vitamin d

Country Status (11)

Country Link
US (3) US20160228458A1 (en)
EP (1) EP3003497B1 (en)
JP (2) JP6608810B2 (en)
KR (1) KR20160013201A (en)
CN (2) CN105492081A (en)
AU (4) AU2014274099A1 (en)
CA (1) CA2913543C (en)
HK (1) HK1222819A1 (en)
NZ (1) NZ714801A (en)
SG (2) SG10201709894RA (en)
WO (1) WO2014194133A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5978130B2 (en) 2009-08-14 2016-08-24 バーグ エルエルシー Vitamin D3 and analogs thereof for treating alopecia
SG10201709894RA (en) * 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
JP7208016B2 (en) * 2016-06-05 2023-01-18 バーグ エルエルシー Prevention or reduction of chemotherapy-induced alopecia using vitamin D
US20180177700A1 (en) * 2016-12-28 2018-06-28 Adam M. Rotunda Hair removal compositions and methods
EP3761988A4 (en) * 2018-03-07 2021-12-29 Athenex HK Innovative Limited Compositions and methods for treating hyperproliferative skin disorders

Family Cites Families (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4307231A (en) 1980-07-18 1981-12-22 Wisconsin Alumni Research Foundation Vitamin D-lactone derivative and process for preparing same
US4336193A (en) 1980-08-04 1982-06-22 Wisconsin Alumni Research Foundation Process for preparing vitamin D-lactones
US4367177A (en) 1981-04-15 1983-01-04 Wisconsin Alumni Research Foundation Process for preparing 23,25-dihydroxyvitamin D3
US4279826A (en) 1980-09-22 1981-07-21 Wisconsin Alumni Research Foundation 23,25-Dihydroxyvitamin D3
US4305880A (en) 1980-09-22 1981-12-15 Wisconsin Alumni Research Foundation Process for preparing 24-fluoro-25-hydroxycholecalciferol
US4307025A (en) 1981-02-17 1981-12-22 Wisconsin Alumni Research Foundation 1α, 25-dihydroxy-2β-fluorovitamin D3
JPS57149224A (en) 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4360472A (en) 1981-12-11 1982-11-23 Wisconsin Alumni Research Foundation Trihydroxyvitamin D3 compounds
US4360471A (en) 1981-12-11 1982-11-23 Wisconsin Alumni Research Foundation 23-Dehydro-25-hydroxyvitamin D3
US4411833A (en) 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
US4428946A (en) 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
US4448721A (en) 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US5036061A (en) 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4448726A (en) 1983-05-11 1984-05-15 Wisconsin Alumni Research Foundation Ring A- and triene-modified vitamin D compounds
US4564474A (en) 1983-08-18 1986-01-14 Wisconsin Alumni Research Foundation 23,23-Difluoro-25-hydroxy-vitamin D3 and process for preparing same
US4502991A (en) 1983-08-18 1985-03-05 Wisconsin Alumni Research Foundation 23,23-Difluoro-1α,25-dihydroxy-vitamin D3
US4769181A (en) 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4719205A (en) 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
US4689180A (en) 1984-01-30 1987-08-25 Wisconsin Alumni Research Foundation 1α,25-dihydroxy-22Z-dehydroxyvitamin D compound
US4505906A (en) 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4481198A (en) 1984-02-13 1984-11-06 Wisconsin Alumni Research Foundation Vitamin D metabolism inhibitor
US4719204A (en) 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US4588716A (en) 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4857518A (en) 1984-10-04 1989-08-15 Wisconsin Alumni Research Foundation Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same
US4717721A (en) 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity
JPS62501505A (en) 1985-01-17 1987-06-18 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン vitamin D derivatives
US4594192A (en) 1985-03-20 1986-06-10 Wisconsin Alumni Research Foundation 2α-fluorovitamin D3
JPS62502545A (en) 1985-04-23 1987-10-01 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン Secosterol compounds
US4755329A (en) 1985-06-10 1988-07-05 Wisconsin Alumni Research Foundation Process and intermediates for preparing 1α-hydroxyvitamin D compounds
US4619920A (en) 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US4847012A (en) 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
US4927815A (en) 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US5354744A (en) 1988-04-29 1994-10-11 Wisconsin Alumni Research Foundation Side chain unsaturated 1 alpha-hydroxyvitamin D analogs
US5250523A (en) 1988-04-29 1993-10-05 Wisconsin Alumni Research Foundation Side chain unsaturated 1α-hydroxyvitanim D homologs
US5232836A (en) 1988-05-04 1993-08-03 Ire-Medgenix S.A. Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5321018A (en) 1989-03-09 1994-06-14 Wisconsin Alumni Research Foundation Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
US4973584A (en) 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
US5246925A (en) 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
DE3933034A1 (en) 1989-10-02 1991-04-11 Schering Ag 24-HOMO-VITAMIN-D DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF
US5254538A (en) 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5532228A (en) 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
US5260290A (en) 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5185150A (en) 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5086191A (en) 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
AU650751B2 (en) 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
ES2093180T3 (en) 1991-07-05 1996-12-16 Duphar Int Res VITAMIN D COMPOUND, METHOD OF PREPARING THIS COMPOUND AND INTERMEDIATE PRODUCT OF SUCH METHOD.
EP0549318B1 (en) 1991-12-26 1996-10-16 Wisconsin Alumni Research Foundation 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same
US5830885A (en) 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
AU666529B2 (en) 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
KR960013798B1 (en) 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 Optic switch
JP2876547B2 (en) 1992-06-23 1999-03-31 呉羽化学工業株式会社 Anti-Kur disease agent
DE4220757A1 (en) 1992-06-24 1994-01-05 Schering Ag Derivatives in the vitamin D series with modifications in the 20-position, process for their preparation, intermediates for this process, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicaments
DE4221961A1 (en) 1992-06-30 1994-01-05 Schering Ag 22-en-25-oxa derivatives in the vitamin D series, processes for their preparation, pharmaceutical preparations containing these derivatives and their use as medicines
GB9214202D0 (en) 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
US5194431A (en) 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
AU666563B2 (en) 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
IL103224A (en) 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
GB9220272D0 (en) 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
IL107185A (en) 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
GB9223061D0 (en) 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5247104A (en) 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
DE69230151T2 (en) * 1992-12-04 2000-03-09 Mayor Pharma Lab Inc SPRAYABLE ANALGETIC COMPOSITION AND METHOD FOR IRAL USE
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
AU5853894A (en) 1992-12-29 1994-07-19 Michael F. Holick Use of vitamin d glycosides for the treatment or prevention of osteoporosis
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
US5371249A (en) 1993-05-11 1994-12-06 Wisconsin Alumni Research Foundation Iodo vitamin D3 compounds and method for preparing same
US5449668A (en) 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
NZ271332A (en) 1993-07-09 2001-03-30 Theramex Vitamin D analogues and pharmaceutical use
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5565589A (en) 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5384313A (en) 1993-11-24 1995-01-24 Wisconsin Alumni Research Foundation 21-norvitamin D compounds
US5373004A (en) 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
GB9325415D0 (en) 1993-12-13 1994-02-16 Res Inst Medicine Chem Chemical compounds
US6103709A (en) 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
GB9405715D0 (en) 1994-03-23 1994-05-11 Res Inst Medicine Chem Chemical compounds
KR100244060B1 (en) 1994-04-11 2000-02-01 나가야마 오사무 22-thiavitamin d 3 derivative
KR970707089A (en) 1994-11-21 1997-12-01 리차드 에이취. 리이저 18, 19-Dinor-Vitamin D Compounds < RTI ID = 0.0 >
US5661140A (en) 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
ATE178596T1 (en) 1994-12-14 1999-04-15 Duphar Int Res VITAMIN D DERIVATIVES AND METHOD FOR PRODUCING THESE COMPOUNDS
CA2210106A1 (en) 1995-01-23 1996-08-01 Yoshiyuki Ono Vitamin d3 derivatives having a substituent at the 2-position
US5877168A (en) 1995-02-10 1999-03-02 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivative with substituent at the 2β-position
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
EP0832063B1 (en) 1995-06-14 2000-02-23 Schering Aktiengesellschaft Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
PT771789E (en) 1995-10-30 2000-05-31 Hoffmann La Roche 1 ALPHA 26-DI-HYDROXY-D-HOMO-VITAMIN D3
GB9524812D0 (en) 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9526208D0 (en) 1995-12-21 1996-02-21 Res Inst Medicine Chem Chemical compounds
GB9607034D0 (en) 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
US6288249B1 (en) 1996-05-02 2001-09-11 Kingdom Of The Netherlands Vitamin D analogs and methods of preparing these compounds
JPH09299484A (en) * 1996-05-10 1997-11-25 Maeda Sangyo Kk Syringe spray pump
GB9611603D0 (en) 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US5976784A (en) 1996-09-20 1999-11-02 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
GB9622590D0 (en) 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
PT947504E (en) 1996-12-20 2003-12-31 Chugai Pharmaceutical Co Ltd VITAMIN D 16-ENO DERIVATIVES
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US5945410A (en) 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
ES2196476T3 (en) 1997-05-02 2003-12-16 Duphar Int Res A METHOD OF PREPARING COMPOUNDS OF 16-DEHYDRO-VITAMIN D.
AU744471B2 (en) 1997-05-16 2002-02-21 Women & Infants Hospital 3-epi vitamin D2 compounds and uses thereof
CA2290772A1 (en) 1997-05-22 1998-11-26 Cephalon, Inc. Vitamin d analogues and their neuronal effects
AU7454698A (en) * 1997-06-06 1998-12-21 Shionogi & Co., Ltd. Improvement in medicament administration system
US5936105A (en) 1997-06-13 1999-08-10 Tetrionics, Inc. 14-EPI-19-nor-vitamin D compounds and methods
US5939406A (en) 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US6359152B2 (en) 1997-07-21 2002-03-19 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
GB9721156D0 (en) 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
US5919986A (en) 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
US6043385A (en) 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
US6184422B1 (en) 1998-02-26 2001-02-06 Hoffman-La Roche Inc. Cyclohexanediol derivatives
CA2326117A1 (en) 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
AU3167699A (en) 1998-04-10 1999-11-01 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivatives substituted at the 2beta-position
US6114317A (en) 1998-05-21 2000-09-05 Wisconsin Alumni Research Foundation Method of locking 1α-OH of vitamin D compounds in axial orientation
IL139354A (en) 1998-05-29 2005-08-31 Bone Care Internat Inc Method for making hydroxy-25 ene-vitamin d compounds
US5972917A (en) 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
US6218430B1 (en) 1998-08-24 2001-04-17 Ligand Pharmaceuticals Incorporated Vitamin D3 mimics
FR2785284B1 (en) 1998-11-02 2000-12-01 Galderma Res & Dev VITAMIN D ANALOGS
FR2801307B1 (en) 1999-11-24 2002-12-06 Galderma Res & Dev VITAMIN D ANALOGS
FR2801305B1 (en) 1999-11-24 2002-12-06 Galderma Res & Dev VITAMIN D ANALOGS
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
AU2004247109A1 (en) 2003-06-11 2004-12-23 Novacea, Inc Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
WO2005037755A2 (en) 2003-10-14 2005-04-28 X-Ceptor Therapeutics, Inc. Bridged ring structures as pharmaceutical agents
DK1686972T3 (en) * 2003-11-21 2008-06-30 Galderma Res & Dev Sprayable preparation for administration of vitamin D derivatives
FR2862540B1 (en) * 2003-11-21 2007-03-30 Galderma Res & Dev SPRAY COMPOSITION COMPRISING A PHARMACEUTICAL ACTIVE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE NON-POLAR PHASE
FR2871697B1 (en) 2004-06-17 2007-06-29 Galderma Sa SPRAY COMPOSITION COMPRISING AN ASSOCIATION OF PHARMACEUTICAL ASSETS, AN ALCOHOLIC PHASE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE OIL PHASE
CN1732902A (en) * 2005-09-01 2006-02-15 晏四平 Vitamin contained spray
US8530463B2 (en) * 2007-05-07 2013-09-10 Hale Biopharma Ventures Llc Multimodal particulate formulations
JP5978130B2 (en) * 2009-08-14 2016-08-24 バーグ エルエルシー Vitamin D3 and analogs thereof for treating alopecia
SG10201709894RA (en) * 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Also Published As

Publication number Publication date
AU2014274099A1 (en) 2015-12-24
NZ714801A (en) 2021-07-30
EP3003497A4 (en) 2017-01-04
US20220023317A1 (en) 2022-01-27
CN112156097A (en) 2021-01-01
SG10201709894RA (en) 2018-01-30
AU2023270234A1 (en) 2023-12-14
KR20160013201A (en) 2016-02-03
US20200113918A1 (en) 2020-04-16
AU2019222786A1 (en) 2019-09-12
WO2014194133A1 (en) 2014-12-04
CA2913543A1 (en) 2014-12-04
EP3003497A1 (en) 2016-04-13
JP2016523226A (en) 2016-08-08
US20160228458A1 (en) 2016-08-11
CN105492081A (en) 2016-04-13
AU2021203977A1 (en) 2021-07-08
JP2020023563A (en) 2020-02-13
JP6608810B2 (en) 2019-11-20
WO2014194133A8 (en) 2015-01-15
HK1222819A1 (en) 2017-07-14
EP3003497B1 (en) 2024-02-14
CA2913543C (en) 2024-01-09

Similar Documents

Publication Publication Date Title
HK1215795A1 (en) Amatoxin derivatives
PL3024827T3 (en) Substituted quinazolin-4-one derivatives
SG11201505309TA (en) Benzylamine derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
IL241014A0 (en) Inhibiting or reducing fungal growth
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
SG11201507543RA (en) Drilling riser assemblies
SG11201605189YA (en) Imidazopyrazinone derivatives
HK1222819A1 (en) Preventing or mitigating chemotherapy in uce alopecia using vitamin
HK1218518A1 (en) Compositions and methods for reducing or preventing metastasis
HK1216099A1 (en) Benzylamine derivatives
HK1219728A1 (en) New anti-malarial agents
GB2501418B (en) Automatically adjusting gravity-equilibrator
EP3463283A4 (en) Preventing or mitigating chemotherapy induced alopecia using vitamin d
GB201306424D0 (en) Reducing interference
PL2803817T3 (en) Milling device
AU4959P (en) DP401 Dianella prunina x caerulea
GB201313160D0 (en) Seenite mini
GB201308537D0 (en) Frameless seating